|Systematic (IUPAC) name|
|Mol. mass||231.293 g/mol|
|Melt. point||106–107 °C (223–225 °F)|
|(what is this?)|
AL-38022A is an indazole derivative drug which is one of a range of similar drugs developed for scientific research and with some possible clinical applications. It acts as a potent and selective agonist for the 5-HT2 family of serotonin receptors, with highest binding affinity for the 5-HT2C subtype and around 4x less affinity for 5-HT2A and 5-HT2B. In drug discrimination tests on animals, it fully substituted for both DOM and 5-MeO-DMT.
- May, JA; Sharif, NA; Chen, HH; Liao, JC; Kelly, CR; Glennon, RA; Young, R; Li, JX; Rice, KC; France, CP (2009). "Pharmacological properties and discriminative stimulus effects of a novel and selective 5-HT2 receptor agonist AL-38022A (S)-2-(8,9-dihydro-7H-pyrano2,3-gindazol-1-yl)-1-methylethylamine". Pharmacology, Biochemistry, and Behavior 91 (3): 307–14. doi:10.1016/j.pbb.2008.07.015. PMID 18718483.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|
|This article about an amine is a stub. You can help Wikipedia by expanding it.|